Tags

Type your tag names separated by a space and hit enter

Psoriasis.
Am Fam Physician. 2013 May 01; 87(9):626-33.AF

Abstract

Psoriasis is a chronic inflammatory skin condition that is often associated with systemic manifestations. It affects about 2 percent of U.S. adults, and can significantly impact quality of life. The etiology includes genetic and environmental factors. Diagnosis is based on the typical erythematous, scaly skin lesions, often with additional manifestations in the nails and joints. Plaque psoriasis is the most common form. Atypical forms include guttate, pustular, erythrodermic, and inverse psoriasis. Psoriasis is associated with several comorbidities, including cardiovascular disease, lymphoma, and depression. Topical therapies such as corticosteroids, vitamin D analogs, and tazarotene are useful for treating mild to moderate psoriasis. More severe psoriasis may be treated with phototherapy, or may require systemic therapy. Biologic therapies, including tumor necrosis factor inhibitors, can be effective for severe psoriasis and psoriatic arthritis, but have significant adverse effect profiles and require regular monitoring. Management of psoriasis must be individualized and may involve combinations of different medications and phototherapy.

Authors+Show Affiliations

Duke University School of Medicine, Durham, NC 27710, USA. nancy.weigle@duke.eduNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

23668525

Citation

Weigle, Nancy, and Sarah McBane. "Psoriasis." American Family Physician, vol. 87, no. 9, 2013, pp. 626-33.
Weigle N, McBane S. Psoriasis. Am Fam Physician. 2013;87(9):626-33.
Weigle, N., & McBane, S. (2013). Psoriasis. American Family Physician, 87(9), 626-33.
Weigle N, McBane S. Psoriasis. Am Fam Physician. 2013 May 1;87(9):626-33. PubMed PMID: 23668525.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Psoriasis. AU - Weigle,Nancy, AU - McBane,Sarah, PY - 2013/5/15/entrez PY - 2013/5/15/pubmed PY - 2013/7/10/medline SP - 626 EP - 33 JF - American family physician JO - Am Fam Physician VL - 87 IS - 9 N2 - Psoriasis is a chronic inflammatory skin condition that is often associated with systemic manifestations. It affects about 2 percent of U.S. adults, and can significantly impact quality of life. The etiology includes genetic and environmental factors. Diagnosis is based on the typical erythematous, scaly skin lesions, often with additional manifestations in the nails and joints. Plaque psoriasis is the most common form. Atypical forms include guttate, pustular, erythrodermic, and inverse psoriasis. Psoriasis is associated with several comorbidities, including cardiovascular disease, lymphoma, and depression. Topical therapies such as corticosteroids, vitamin D analogs, and tazarotene are useful for treating mild to moderate psoriasis. More severe psoriasis may be treated with phototherapy, or may require systemic therapy. Biologic therapies, including tumor necrosis factor inhibitors, can be effective for severe psoriasis and psoriatic arthritis, but have significant adverse effect profiles and require regular monitoring. Management of psoriasis must be individualized and may involve combinations of different medications and phototherapy. SN - 1532-0650 UR - https://www.unboundmedicine.com/medline/citation/23668525/full_citation DB - PRIME DP - Unbound Medicine ER -